WHO monitors spread of PJ.2.1 coronavirus variant

The PJ.2.1 variant has been detected in Canada, the US, and Spain, but officials say there is no evidence it causes more severe disease.

The first confirmed sample of PJ.2.1 was detected on May 2, 2026, in Ontario, Canada. The variant was later identified in other parts of Canada and in several US states on June 30.

World Health Organization officials have announced there is currently insufficient evidence to conclude that the PJ.2.1 variant causes more severe disease than earlier variants. Laboratory and clinical data show no clear or significant difference in the severity of the disease associated with the strain. An increase in the prevalence of a variant within certain communities does not necessarily imply a rise in its clinical severity.

The World Health Organization is closely monitoring the evolution of the strain and its regional and international spread. National and international health authorities have increased preparedness to monitor genetic developments and assess potential risks. Officials emphasize the importance of viewing these developments without alarmism, noting the strain should not be viewed in isolation from the immunity populations have built up.

Physicians and specialists emphasize that the absence of conclusive evidence regarding increased severity does not mean there is no risk, particularly for the elderly, individuals with compromised immune systems, or those with chronic respiratory or heart conditions. The organization recommends adhering to fundamental preventive measures and receiving updated vaccinations.

The WHO Technical Advisory Group on COVID-19 Vaccine Composition will consider data on the PJ.2.1, ST.1, and SW.2.1 variants during discussions in December 2026. The group will analyze information on genetic evolution, epidemiology, antigenic characteristics, immunogenicity, and vaccine effectiveness.

Key facts

  • The first confirmed sample of PJ.2.1 was detected on May 2, 2026, in Ontario, Canada.
  • There is currently no sufficient scientific evidence to suggest the PJ.2.1 variant causes more severe symptoms than previous variants.
  • The WHO Technical Advisory Group on COVID-19 Vaccine Composition will review data on PJ.2.1, ST.1, and SW.2.1 in December 2026.

Three perspectives

Neutral

The PJ.2.1 coronavirus variant has been detected in North America and Europe, but current data shows no significant difference in disease severity compared to earlier strains.

Positive

The World Health Organization is closely monitoring the strain and its genetic evolution to ensure an effective international health response.

Negative

The risk of the PJ.2.1 strain spreading globally is increasing, posing potential risks to the elderly and those with chronic illnesses.

Your week in news, every Wednesday

The biggest stories of the week for your edition, in your inbox every Wednesday morning, your time. Free, and you can unsubscribe at any time.

Choose your news coverage

Please choose and confirm your coverage.

All sections

Edition